Publications by Dr Michelle Eagle - ePrints

Browsing publications by Dr Michelle Eagle.

Newcastle Authors	Title	Year
Dr Marianela Schiava Robert Muni Lofra Dr John Bourke Meredith James Professor Jordi Diaz Manera et al.	Disease-associated comorbidities, medication records and anthropometric measures in adults with Duchenne muscular dystrophy	2024
Meredith James Dr Michelle Eagle Robert Muni Lofra Dr ursula Moore Professor Michela Guglieri et al.	Assessing Dysferlinopathy Patients Over Three Years With a New Motor Scale	2022
Professor Michela Guglieri Emerita Professor Katherine Bushby Emerita Professor Elaine McColl Chris Speed Jennifer Wilkinson et al.	Effect of Different Corticosteroid Dosing Regimens on Clinical Outcomes in Boys With Duchenne Muscular Dystrophy: A Randomized Clinical Trial	2022
Dr Anna Mayhew Dionne Moat Dr Michelle Eagle Meredith James Robert Muni Lofra et al.	Functional outcome measures in young, steroid-naïve boys with Duchenne muscular dystrophy	2022
Meredith James Robert Muni Lofra Dionne Moat Mark Richardson Dr Michelle Eagle et al.	Validation of the North Star Assessment for Limb-Girdle Type Muscular Dystrophies	2022
Meredith James Dr Michelle Eagle	Remote Delivery of Motor Function Assessment and Training for Clinical Trials in Neuromuscular Disease: A Response to the COVID-19 Global Pandemic	2021
Dr Anna Mayhew Roberto Fernandez-Torron Dr Michelle Eagle Karen Bettinson Professor Andrew Blamire et al.	Assessment of disease progression in dysferlinopathy – a 1 year cohort study	2019
Dr Alex Murphy Meredith James Dr Anna Mayhew Dr Michelle Eagle Dr Kieren Hollingsworth et al.	Natural history of limb girdle musclar dystrophy R9 over 6 years: searching for trial endpoints	2019
Rebecca Crow Emerita Professor Elaine McColl Dr Jennifer Wilkinson Dr Michelle Eagle Professor Hanns Lochmuller et al.	A checklist for clinical trials in rare disease: obstacles and anticipatory actions—lessons learned from the FOR-DMD trial	2018
Professor Jordi Diaz Manera Roberto Fernandez-Torron Meredith James Dr Anna Mayhew Dr Fiona Smith et al.	Muscle MRI in dysferlinopathy patients: Pattern recognition and implications for clinical trials	2018
Dr Ursula Moore Roberto Fernandez-Torron Meredith James Dr Anna Mayhew Dr Michelle Eagle et al.	Teenage exercise is associated with earlier symptom onset in dysferlinopathy: a retrospective cohort study	2018
Dr Michelle Eagle	A phase 3 randomized placebo-controlled trial of tadalafil for Duchenne muscular dystrophy	2017
Dr Michelle Eagle	Aquatic therapy for children with duchenne muscular dystrophy: A pilot feasibility randomised controlled trial and mixed-methods process evaluation	2017
Professor Michela Guglieri Emerita Professor Katherine Bushby Emerita Professor Elaine McColl Dr Jennifer Wilkinson Dr Michelle Eagle et al.	Developing standardized corticosteroid treatment for Duchenne muscular dystrophy	2017
Dr Ursula Moore Meredith James Dr Anna Mayhew Dr Fiona Smith Dr Lizzie Harris et al.	Clinical outcome study for dysferlinopathy: One-year follow-up	2016
Dr Anna Mayhew Dr Michelle Eagle Professor Michela Guglieri Professor Volker Straub Professor Hanns Lochmuller et al.	Corrigendum to Development and psychometric analysis of the Duchenne muscular dystrophy Functional Ability Self-Assessment Tool (DMDSAT) (vol 25, pg 937, 2015)	2016
Dr Michelle Eagle Dr Anna Mayhew Professor Michela Guglieri Professor Volker Straub	Outcome measures for Duchenne muscular dystrophy from ambulant to non-ambulant: Implications for clinical trials	2016
David Rawlings Dr Claire Wood Professor Timothy Cheetham Dr Cecilia Jimenez Moreno Dr Anna Mayhew et al.	Prophylactic oral bisphosphonate therapy in duchenne muscular dystrophy	2016
Dr Lizzie Harris Dr Catherine Bladen Dr Anna Mayhew Meredith James Karen Bettinson et al.	The Clinical Outcome Study for dysferlinopathy: An international multicenter study	2016
Dr Henriette van Ruiten Professor Chiara Marini Bettolo Professor Timothy Cheetham Dr Michelle Eagle Professor Hanns Lochmuller et al.	Why are some patients with Duchenne muscular dystrophy dying young: An analysis of causes of death in North East England	2016
Rebecca Crow Professor Michela Guglieri Emerita Professor Elaine McColl Dr Jennifer Wilkinson Dr Michelle Eagle et al.	Anticipating and overcoming obstacles in setting up NIH funded academic led, international clinical trials in rare disease - learning from for DMD	2015
Dr Michelle Eagle	Baseline characteristics of the CINRG infantile facioscapulohumeral muscular dystrophy cohort	2015
Professor Volker Straub Olav Veldhuizen Dr Marta Bertoli Dr Michelle Eagle	Consortium for Products Across Europe in Duchenne Muscular Dystrophy (SCOPE-DMD)	2015
Dr Anna Mayhew Dr Michelle Eagle Professor Michela Guglieri Professor Volker Straub Professor Hanns Lochmuller et al.	Development and Psychometric Analysis of the Duchenne Muscular Dystrophy Functional Ability Self-Assessment Tool (DMDSAT)	2015
Dr Michelle Eagle	Does an inability to achieve plantargrade at the ankle joint have an impact on the outcome measures of the six minute walking test and North Star ambulatory assessment; and is this further compounded by illio-tibial band tightness?	2015
Dr Cecilia Jimenez Moreno Dr Sira Moreno Dr Michelle Eagle Dr Anna Mayhew Meredith James et al.	Impact of three decades of improvement in standards of care for Duchenne muscular dystrophy	2015
Dr Michelle Eagle Professor Michela Guglieri Professor Volker Straub	Outcome measures for Duchenne muscular dystrophy from ambulant to non-ambulant: Implications for clinical trials	2015
Dr Henriette van Ruiten Professor Michela Guglieri Dr Michelle Eagle Professor Volker Straub Professor Hanns Lochmuller et al.	Overview of morbidity, mortality and survival in Duchenne muscular dystrophy in the North East of England	2015
Dr Anna Mayhew Meredith James Dr Michelle Eagle Dr Catherine Bladen Karen Bettinson et al.	Preparation of a disease specific functional measure suitable for trials in dysferlinopathy	2015
Professor Michela Guglieri Emerita Professor Elaine McColl Dr Jennifer Wilkinson Dr Michelle Eagle Emerita Professor Katherine Bushby et al.	Recruitment in the FOR-DMD study - double-blind randomized trial to optimize steroid regime in Duchenne Muscular Dystrophy (DMD)	2015
Emerita Professor Katherine Bushby Dr Michelle Eagle	Ataluren treatment of patients with nonsense mutation dystrophinopathy	2014
Dr Michelle Eagle Emerita Professor Katherine Bushby	Hammersmith Functional Motor Scale and Motor Function Measure-20 in non ambulant SMA patients	2014
Dr Lizzie Harris Karen Bettinson Meredith James Dr Anna Mayhew Dr Michelle Eagle et al.	International Clinical Outcome Study in Dysferlinopathy (COS): Results of screening questionnaires in UK patients	2014
Dr Michelle Eagle Emerita Professor Katherine Bushby	One Year Outcome of Boys With Duchenne Muscular Dystrophy Using the Bayley-III Scales of Infant and Toddler Development	2014
Dr Tracey Willis Dr Kieren Hollingsworth Dr Michelle Eagle Dr Anna Mayhew Emerita Professor Katherine Bushby et al.	Quantitative Magnetic Resonance Imaging in Limb-Girdle Muscular Dystrophy 2I: A Multinational Cross-Sectional Study	2014
Professor Volker Straub Dr Michelle Eagle Professor Michela Guglieri	Safety and efficacy of drisapersen for the treatment of Duchenne muscular dystrophy (DEMAND II): an exploratory, randomised, placebo-controlled phase 2 study	2014
Dr Amina Chaouch Dr Fiona Norwood Professor Rita Horvath Professor Patrick Chinnery Dr Tuomo Polvikoski et al.	Two recurrent mutations are associated with GNE myopathy in the North of Britain	2014
Dr Anna Sarkozy Dr Debbie Hicks Dr Steven Laval Dr Rita Barresi Dr Lizzie Harris et al.	ANO5 Gene Analysis in a Large Cohort of Patients with Anoctaminopathy: Confirmation of Male Prevalence and High Occurrence of the Common Exon 5 Gene Mutation	2013
Dr Michelle Eagle Dr Anna Mayhew Karen Bettinson Meredith James Dr Brigitta von Rekowski et al.	Clinical outcome measures for dysferlinopathy: An exploration of reliability and suitability of novel functional rating scales	2013
Dr Anna Mayhew Dr Michelle Eagle Emerita Professor Katherine Bushby	Detecting meaningful change using the North Star Ambulatory Assessment in Duchenne muscular dystrophy	2013
Dr Kieren Hollingsworth Dr Penelope Garrood Dr Michelle Eagle Emerita Professor Katherine Bushby Professor Volker Straub et al.	Magnetic resonance imaging in duchenne muscular dystrophy: Longitudinal assessment of natural history over 18 months	2013
Dr Anna Mayhew Dr Michelle Eagle Meredith James Emerita Professor Katherine Bushby	Performance of Upper Limb Scale for use in Duchenne muscular dystrophy - An iterative process to establish its suitability for clinical trials	2013
Matias Wagner Dr Amina Chaouch Dr Juliane Mueller Dr Tuomo Polvikoski Dr Tracey Willis et al.	Presymptomatic late-onset Pompe disease identified by the dried blood spot test	2013
Dr Tracey Willis Dr Kieren Hollingsworth Dr Michelle Eagle Dr Anna Mayhew Emerita Professor Katherine Bushby et al.	Quantitative Muscle MRI as an Assessment Tool for Monitoring Disease Progression in LGMD2I: A Multicentre Longitudinal Study	2013
Dr Liesbeth De Waele Dr Michelle Eagle Dr Richard Charlton Dr Langping He Dr Emma Watson et al.	Recessive desmin-null muscular dystrophy with central nuclei and mitochondrial abnormalities	2013
Meredith James Dr Michelle Eagle Dr Anna Mayhew	Clinical Evaluator training for the GSK DEMAND programme	2012
Dr Michelle Eagle Dr Anna Mayhew Dr Eugen-Matthias Strehle	Development of a Functional Assessment Scale for Ambulatory Boys with Duchenne Muscular Dystrophy	2012
Dr Michelle Eagle Dr Anna Mayhew	Development of an upper limb functional scale in dystrophinopathies	2012
Dr Anna Mayhew Dr Michelle Eagle	Exploratory Rasch analysis of the EK2 scale used in a population of Duchenne muscular dystrophy (DMD)	2012
Dr Anna Sarkozy Dr Tuomo Polvikoski Dr Michelle Eagle Professor Hanns Lochmuller Emerita Professor Katherine Bushby et al.	Progressive core myopathy with dilated cardiomyopathy, respiratory failure and severe scoliosis caused by a novel mutation in the MYH7 gene	2012
Dr Anna Mayhew Dr Michelle Eagle Emerita Professor Katherine Bushby	Trial readiness: Clinical interpretability of change scores of the North Star Ambulatory Assessment in Duchenne muscular dystropy	2012
Dr Debbie Hicks Dr Anna Sarkozy Dr Nuria Muelas Gomez Professor Gavin Hudson Professor Patrick Chinnery et al.	A founder mutation in Anoctamin 5 is a major cause of limb girdle muscular dystrophy	2011
Dr Debbie Hicks Dr Anna Sarkozy Dr Nuria Muelas Gomez Professor Gavin Hudson Professor Patrick Chinnery et al.	A founder mutation in Anoctamin 5 is a major cause of limb-girdle muscular dystrophy	2011
Dr Tracey Willis Dr Kieren Hollingsworth Dr Michelle Eagle Dr Anna Mayhew Emerita Professor Katherine Bushby et al.	Assessing muscle pathology by MRI in LGMD2I	2011
Dr Michelle Eagle	Assessing upper limb function in nonambulant SMA patients: Development of a new module	2011
Professor Michela Guglieri Dr Michelle Eagle Emerita Professor Katherine Bushby	Body mass index (BMI) and growth in Duchenne Muscular Dystrophy (DMD)	2011
Dr Anna Mayhew Dr Michelle Eagle Dr Tracey Willis Professor Volker Straub	Exploratory Rasch analysis of adapted North Star ambulatory assessment in LGMD 2I	2011
Dr Anna Mayhew Dr Michelle Eagle Emerita Professor Katherine Bushby Professor Volker Straub Dr Anna Sarkozy et al.	Moving towards meaningful measurement: Rasch analysis of the North Star Ambulatory Assessment in Duchenne muscular dystrophy	2011
Dr Anna Sarkozy Dr Michelle Eagle Dr Richard Charlton Dr Rita Barresi Professor Hanns Lochmuller et al.	Phenotypic heterogeneity in British patients with a founder mutation in the FHL1 gene	2011
Dr Tracey Willis Dr Kieren Hollingsworth Dr Michelle Eagle Dr Anna Mayhew Emerita Professor Katherine Bushby et al.	Quantitative MRI in LGMD2I; a longitudinal study	2011
Dr Tracey Willis Dr Kieren Hollingsworth Dr Michelle Eagle Emerita Professor Katherine Bushby Professor Hanns Lochmuller et al.	Assessing muscle pathology by MRI in LGMD2I	2010
Emerita Professor Katherine Bushby Dr Michelle Eagle	Consensus Statement on Standard of Care for Congenital Muscular Dystrophies	2010
Professor Michela Guglieri Emerita Professor Elaine McColl Dr Michelle Eagle Dr Karen Rafferty Emerita Professor Katherine Bushby et al.	FOR-DMD: double-blind randomized trial to optimize steroid regime in Duchenne Muscular Dystrophy (DMD)	2010
Dr Michelle Eagle Dr Anna Mayhew Dr Tracey Willis Professor Hanns Lochmuller Emerita Professor Katherine Bushby et al.	Functional outcome measures in limb girdle muscular dystrophy 21: Correlations with MRI	2010
Dr Tracey Willis Dr Kieren Hollingsworth Professor Andrew Blamire Dr Michelle Eagle Emerita Professor Katherine Bushby et al.	MRI in LGMD21: a qualitative and quantitative analysis using the 3 point Dixon technique	2010
Dr Lars Klinge Dr Michelle Eagle Dr John Hudson Dr Anna Sarkozy Dr Richard Charlton et al.	New aspects on patients affected by dysferlin deficient muscular dystrophy	2010
Emerita Professor Katherine Bushby Dr Michelle Eagle	The Respiratory Management of Patients With Duchenne Muscular Dystrophy: A DMD Care Considerations Working Group Specialty Article	2010
Dr Michelle Eagle	Assessment of StepWatch (TM) activity monitoring in phase 2b study of ataluren (PTC124 (TM)) in nmDMD/BMD	2009
Dr Penelope Garrood Dr Kieren Hollingsworth Dr Michelle Eagle Dr Benjamin Aribisala Dr Daniel Birchall et al.	MR Imaging in Duchenne Muscular Dystrophy: Quantification of T-1-Weighted Signal, Contrast Uptake, and the Effects of Exercise	2009
Professor Timothy Cheetham Professor Simon Pearce David Rawlings Dr Michelle Eagle Professor Michela Guglieri et al.	Oral bisphosphonates as prophylaxis of steroid-induced osteoporosis in Duchenne muscular dystrophy	2009
Dr Fiona Norwood Professor Patrick Chinnery Dr Michelle Eagle Emerita Professor Katherine Bushby Professor Volker Straub et al.	Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population	2009
Dr Michelle Eagle	Reliability of the North Star Ambulatory Assessment in a multicentric setting	2009
Dr Michelle Eagle Lisa Atkinson	T.P.3.05: Reproducibility and correlation of pretreatment outcome measures in phase 2b study of ataluren (PTC124 (TM)) in nonsense mutation Duchenne and Becker muscular dystrophy (nmDMD/BMD)	2009
Emerita Professor Katherine Bushby Dr Michelle Eagle Dr Eugen-Matthias Strehle Professor Volker Straub	13th International WMS Congress, 29th September - 2nd October 2008, Newcastle Gateshead, UK	2008
Emerita Professor Katherine Bushby Dr Michelle Eagle Professor Volker Straub	A phase I/II trial of MYO-029 in adult subjects with muscular dystrophy	2008
Dr Richard Charlton Dr Rita Barresi Dr Michelle Eagle Emerita Professor Katherine Bushby Professor Volker Straub et al.	Caveolinopathy - New mutations and additional symptoms	2008
Professor Michela Guglieri Geoff Bell Dr John Bourke Dr Michelle Eagle Professor Patrick Chinnery et al.	Clinical follow up in a large cohort of patients affected by Myotonic Dystrophy type	2008
Professor Michela Guglieri Geoff Bell Dr John Bourke Dr Michelle Eagle Professor Patrick Chinnery et al.	D.P.2.02: Development of a nurse led multidisciplinary clinic for myotonic dystrophy type 1	2008
Professor Michela Guglieri Geoff Bell Dr John Bourke Dr Michelle Eagle Professor Patrick Chinnery et al.	D.P.2.03: Clinical follow up in a large cohort of patients affected by myotonic dystrophy type 1	2008
Dr Rita Barresi Dr Richard Charlton Dr Michelle Eagle Emerita Professor Katherine Bushby Professor Volker Straub et al.	D.P.3.09: Caveolinopathy - New mutations and additional symptoms	2008
Professor Michela Guglieri Dr Michelle Eagle Dr John Bourke Professor Volker Straub Emerita Professor Katherine Bushby et al.	Delayed development and learning difficulties as a predominant symptom in female carriers of Duchenne and Becker muscular dystrophy	2008
Professor Michela Guglieri Geoff Bell Dr John Bourke Dr Michelle Eagle Professor Patrick Chinnery et al.	Development of a nurse led multidisciplinary clinic for myotonic dystrophy type 1	2008
Dr Michelle Eagle	Egen classification revisited in SMA	2008
Dr Michelle Eagle Emerita Professor Elaine McColl Geoff Bell Emerita Professor Katherine Bushby	Equipoise concerning corticosteroid use in boys with Duchenne muscular dystrophy: persistent wide variations in practice	2008
Professor Michela Guglieri Dr Michelle Eagle Emerita Professor Katherine Bushby Professor Volker Straub	Is assessment of respiratory function a good outcome measure for SMA II and III?	2008
Dr Penelope Garrood Dr Michelle Eagle Emerita Professor Katherine Bushby Professor Volker Straub	Myoglobinuria in boys with Duchenne muscular dystrophy on corticosteroid therapy	2008
Dr Richard Charlton Dr Rita Barresi Dr Louise VB Anderson Dr Michelle Eagle Dr Mauro Santibanez Koref et al.	Analysis of the UK diagnostic strategy for limb girdle muscular dystrophy 2A	2007
Dr Michelle Eagle Professor Michela Guglieri Professor Volker Straub Emerita Professor Katherine Bushby	Long term steroid use in non-ambulatory patients with Duchenne muscular dystrophy	2007
Dr Michelle Eagle Dr John Bourke Dr Robert Bullock Professor Volker Straub Emerita Professor Katherine Bushby et al.	Managing Duchenne muscular dystrophy - The additive effect of spinal surgery and home nocturnal ventilation in improving survival	2007
Dr Penelope Garrood Dr Kieren Hollingsworth Professor Peter Thelwall Dr Daniel Birchall Dr Michelle Eagle et al.	MRI in Duchenne muscular dystrophy: Quantification of fat infiltration and gadolinium uptake using whole-muscle regions of interest	2007
Dr Penelope Garrood Dr Michelle Eagle Emerita Professor Katherine Bushby Professor Volker Straub	Myoglobinuria in steroid-treated Duchenne muscular dystrophy	2007
Dr Michelle Eagle Professor Michela Guglieri Professor Volker Straub Emerita Professor Katherine Bushby	Steroids in Duchenne muscular dystrophy (DMD): Natural history and clinical evaluation using the North Star Ambulatory Assessment (NSAA)	2007
Dr Michelle Eagle	[abstract] The North Star Ambulatory Assessment	2006
Dr Inderbir Gill Dr Michelle Eagle Emerita Professor Katherine Bushby Dr Robert Bullock	Correction of neuromuscular scoliosis in patients with preexisting respiratory failure	2006
Dr Anna Sarkozy Dr Richard Charlton Dr Michelle Eagle Professor Patrick Chinnery Professor Volker Straub et al.	Phenotypic variability associated with desmin gene mutations	2006
Dr Lars Klinge Dr Michelle Eagle Professor Volker Straub Emerita Professor Katherine Bushby	Severe phenotype in infantile facioscapulohumeral muscular dystrophy	2006
Dr Anne Lampe Dr Michelle Eagle Dr Mark Buddles Professor Volker Straub Emerita Professor Katherine Bushby et al.	Bethlem myopathy, autosomal dominant and X-linked Emery Dreifuss muscular dystrophy - comparison of contractural phenotypes	2005
Dr Michelle Eagle David Rawlings Professor Volker Straub Emerita Professor Katherine Bushby	Bone density in patients with Duchenne muscular dystrophy (DMD)	2005
Dr Michelle Eagle Emerita Professor Katherine Bushby Professor Volker Straub	Limb girdle muscular dystrophies - Dominant forms; Poster presentations	2005
Dr Michelle Eagle Professor Volker Straub Emerita Professor Katherine Bushby	The impact of corticosteroids on forced vital capacity in Duchenne muscular dystrophy	2005
Emerita Professor Katherine Bushby Dr John Bourke Dr Robert Bullock Dr Michelle Eagle Mark Gibson et al.	The multidisciplinary management of Duchenne muscular dystrophy	2005
Dr John Bourke Dr Michelle Eagle Professor Volker Straub Emerita Professor Katherine Bushby	Cardiac and respiratory failure in limb-girdle muscular dystrophy 2I	2004
Dr Michelle Eagle Professor Volker Straub Emerita Professor Katherine Bushby	Experience of applying the UK consensus on the use of corticosteroids in DMD	2004
Dr Michelle Eagle Emerita Professor Katherine Bushby	Report of a Muscular Dystrophy Campaign funded workshop to review the prevalence of osteoporosis in DMD and its treatment and prevention	2004
Dr Michelle Eagle Dr Robert Bullock Emerita Professor Katherine Bushby	By simple non-invasive monitoring, the need for ventilation in Duchenne muscular dystrophy can be predicted	2003
Dr Michelle Eagle Dr John Bourke Emerita Professor Katherine Bushby	Experience of spinal surgery and ventilation in 91 patients with Duchenne muscular dystrophy born between 1970 and 1988	2003
Dr Lynsey Cree Dr John Bourke Dr Michelle Eagle Dr Louise VB Anderson Dr Daniel Birchall et al.	The phenotype of limb-girdle muscular dystrophy type 2I	2003
Dr John Bourke Dr Michelle Eagle Emerita Professor Katherine Bushby	Unusual phenotype in a case of laminopathy with childhood onset, short stature, mid-face hypoplasia and early respiratory failure	2003
Dr Michelle Eagle	Exercise in neuromuscular diseases - an expert workshop report	2002
Dr Michelle Eagle	Report on the Muscular Dystrophy Campaign workshop: Exercise in neuromuscular diseases Newcastle, January 2002	2002
Dr Michelle Eagle Dr John Bourke Dr Robert Bullock Dr Lynsey Cree Dr Mark Buddles et al.	Respiratory and cardiac involvement are a primary part of limb-girdle muscular dystrophy 2I	2002
Dr Michelle Eagle Emerita Professor Katherine Bushby	Facioscapulohumeral muscular dystrophy: gait analysis and effectiveness of ankle foot orthoses (AFOs)	2001
Dr Michelle Eagle Dr Robert Bullock Emerita Professor Katherine Bushby	Multicore myopathy: Respiratory failure and paraspinal muscle contractures are important complications	2000